Clinical trials are costly endeavors that often run over budget due to delays in patient enrollment. There are a multitude of factors that cause delays, such as a lack of available patients, high competition for patients/physicians, and clinical trial site fatigue to name a few. Innoplexus’ technology empowers clinical trial coordinators to identify centers likely to have untapped patient populations and underutilized emerging key opinion leaders interested in clinical trial research. Our AI technology accomplishes these feats via network analyses that connect diverse data points to provide insights not otherwise feasible and expedite clinical trials.
Access untapped KOL networks. Identify Top vs. Emerging KOLs and filter them by therapeutic area, location, publications, clinical trials, relationships with pharmaceutical competitors, and numerous customizable filters. Determine which KOLs to engage with based on four KOL archetypes Innoplexus has identified: Commercial, Clinical, Thought-leaders, and Public Speakers.
Accelerate the development of robust clinical trials by quickly comparing trials from over 100+ databases, including clinicaltrials.gov. Connect the outcomes of clinical trials, such as progression to subsequent phases, regulatory approval, and payer decisions with the trial parameters such as trial duration, sample sizes, endpoints, inclusion / exclusion criteria and others to determine the optimal trial design.
Site Optimization & Enrollment